跳至主要内容
临床试验/ISRCTN94266769
ISRCTN94266769已完成Unknown

A single dose of piperacillin plus tazobactam pellicular coating as an adjunct to professional mechanical plaque removal in patients with peri-implant mucositis: a 6-month double-blind randomized clinical trial

MegaGen Dental Implant Romania0 个研究点目标入组 100 人开始时间: 2023年12月5日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age =18 years
  • 2. Absence of relevant medical conditions
  • 3. Partially edentulous subjects with healthy or treated periodontal conditions enrolled in a regular supportive care program
  • 4. Peri-implant mucositis defined as =1 implant site with the presence of BoP and absence of radiographic bone loss compared with a previous radiograph (Renvert, et al., 2018)
  • 5. Implant in function for =1 year
  • 6. Full-Mouth Plaque Score (FMPS) =25
  • 7. Full-Mouth Bleeding Score (FMBS) =25

排除标准

  • 1. Uncontrolled medical conditions
  • 2. Pregnant or lactating females
  • 3. Tobacco smoking =10 cigarettes/day
  • 4. Untreated periodontal conditions
  • 5. Removable implant -retained prosthesis or other chronic systemic medications that could interfere with the study outcomes
  • 6. Use of antibiotics in the past 3 months
  • 7. Subjects treated for =2 weeks with any medication known to affect soft tissue conditions (e.g. phenytoin, calcium antagonists, cyclosporin, blood thinners and nonsteroidal anti-inflammatory drugs) within 1 month of the baseline examination
  • 8. Failure to sign written informed consent

研究者

发起方
MegaGen Dental Implant Romania

相似试验

进行中(未招募)
1 期
Dosage optimization of piperacillin/tazobactam in ICU patients based on therapeutic drug monitoring of amikacin - OPTIMAsepsis or septic shockMedDRA version: 20.0Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestations
EUCTR2018-003496-36-FRHospices Civils de Lyon60
已完成
不适用
Antimicrobial prophylaxis with tazobactam/piperacilin for prevention of postoperative infections after radical cystectomyRadical cystectomy
JPRN-UMIN000005781Kobe University Graduate School of Medicine100
进行中(未招募)
不适用
AObese patients with an infection treated by broad spectrum B-lactams.MedDRA version: 14.1Level: PTClassification code 10060945Term: Bacterial infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2013-000652-18-BEHopital Erasme
进行中(未招募)
不适用
PIPERACILLIN/TAZOBACTAM PLUS TIGECYCLINE VS. PIPERACILLIN/TAZOBACTAM ALONE AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC CANCER PATIENTS : A PROSPECTIVE, RANDOMISED, MULTI-CENTRE, STUDY. - NDeutropenic, febrile cancer patientsMedDRA version: 6.1Level: HLGTClassification code 10004018
EUCTR2006-006210-14-ITIVERSITA' DEGLI STUDI DI PERUGIA
已完成
4 期
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous InfusionInfectious Disease
NCT01198925University Hospital, Ghent14